Annual report pursuant to Section 13 and 15(d)

Common Stock (Details Narrative)

v3.24.1
Common Stock (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Apr. 04, 2023
Jul. 02, 2020
Jan. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Common stock, shares authorized       150,000,000 150,000,000
Common stock, par value       $ 0.001 $ 0.001
Common stock, shares, issued       10,174,000 8,143,000
Common stock, shares, outstanding       10,174,000 8,143,000
Proceeds from common stock       $ 4,000,000
Securities Purchase Agreement [Member] | Two Accredited Investors [Member] | Share-Based Payment Arrangement, Tranche One [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Total purchase price value, investments $ 2,000,000        
Securities Purchase Agreement [Member] | Two Accredited Investors [Member] | Share-Based Payment Arrangement, Tranche Two [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Total purchase price value, investments $ 2,000,000        
Securities Purchase Agreement [Member] | Common Stock [Member] | Two Accredited Investors [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of shares purchase 2,030,458        
Share price $ 1.97        
Total purchase price value, investments $ 4,000,000        
At-The-Market Offering Agreement [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Proceeds from common stock     $ 2,100,000    
Sale of common stock     85,834    
At-The-Market Offering Agreement [Member] | Maximum [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Proceeds from common stock   $ 10,000,000